Intrinsic Value

The intrinsic value of Euronext Athens Holding SA (EXAE) under the Base Case is 7.25 EUR per share. Compared with the current market price of 10.12 EUR, the stock appears Overvalued by 28% .

The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 0% a year over the next five years, less than a third of its five-year pace of 23%. Net margin ends at 34% by 2032, above its five-year average of 29%.

Do our valuations actually work? See backtest results .

EXAE Intrinsic Value
€7.25
Overvaluation 28%
Intrinsic Value
Price €10.12
E

EXAE is more expensive than usual. It was this expensive or more expensive on just 2% of days in the past 5 years.

Monitor EXAE
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €5.8
Get notified when the price drops into your buy zone
Current Price €10.12
Intrinsic Value €7.25
Margin of Safety 20% €5.8
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to EXAE

Fundamental Analysis

What Euronext Athens Does

Financial Services Financials

Hellenic Exchanges Athens Stock Exchange SA runs Greece’s main market infrastructure for listed securities. It matches buyers and sellers of stocks and other exchange-traded instruments, and it also runs the systems that support trading, clearing, settlement, and custody. In simple terms, it is the company behind the Athens stock market’s core plumbing.

Headquarters
Greece GR
Employees
245
IPO date
Aug 21, 2000
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Euronext Athens Holding SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one EXAE stock?

The intrinsic value for Euronext Athens Holding SA (EXAE) under the Base Case is 7.25 EUR.

Is EXAE stock undervalued or overvalued?

Compared with the current market price of 10.12 EUR, the stock appears Overvalued by 28% .

Back to Top